Anagnostics logo

Anagnostics

Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs in protein and infectious disease diagnostics.

est. 2005

VS
mbiomics GmbH logo

mbiomics GmbH

Casting light on the microbiome

44 employees · est. 2020 · Neuried, Germany

Anagnostics is the older company (2005 vs 2020).

Side-by-Side Comparison

Anagnostics mbiomics GmbH
Founded
2005 older 2020
Headquarters
Not tracked yet Neuried, Germany
Employees
Not tracked yet 44
Industry
Biotechnology, Health Care Biotechnology
Funding Stage
Series Unknown Series A
Total Funding
$3.79M $25.00M
Funding Rounds
2 4
Services
Not tracked yet Design and development of microbiome-based therapeutics, Fluorescence microscopy-based profiling technology, Microbiome analytics
Target Customers
Not tracked yet Healthcare Providers, Pharmaceutical Companies, Clinical Researchers
Taxonomy
In-vitro Diagnostics, Protein Diagnostics, Infectious Disease Diagnostics, Research, Clinical, Medical Research, Laboratory Testing, Diagnostic Solutions Microbiome Research, Precision Medicine, Diagnostics, Immuno-oncology, Companion Diagnostics, Therapeutic Development, Personalized Healthcare, Biomedical Research, Healthtech, Disease Prevention, Biological Insights, Clinical Applications
Website
anagnostics.com mbiomics.com
Anagnostics logo

About Anagnostics

Anagnostics is a pioneering company specializing in developing systems and tests for research and clinical in-vitro diagnostics. Established in 2005, the company focuses on addressing unmet needs, particularly in protein and infectious disease diagnostics. Anagnostics aims to provide innovative solu...

mbiomics GmbH logo

About mbiomics GmbH

mbiomics GmbH, headquartered in Germany, is an innovative player in the Biotechnology industry. Established in 2020, the company is driven by the mission of “Casting light on the microbiome,” focusing on revolutionizing understanding of the microbiome to enhance targeted therapies and promote health...

We will tell you when either one moves

BounceWatch watches Anagnostics and mbiomics GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Anagnostics and mbiomics GmbH — by email.

Frequently Asked Questions

Anagnostics — Pioneering systems and tests for research and clinical in-vitro diagnostics to address unmet needs in protein and infectious disease diagnostics.. mbiomics GmbH — Casting light on the microbiome. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Anagnostics has raised $3.79M while mbiomics GmbH has raised $25.00M.
Anagnostics and mbiomics GmbH operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Anagnostics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Anagnostics on 13 Sep 2024, and mbiomics GmbH on 28 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy